ENFN - Enfusion - Stock Forecast

Technology - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ENFN is currently covered by 7 analysts with an average price target of $12.18. This is a potential upside of $1.18 (10.73%) from yesterday's end of day stock price of $11.

Enfusion's activity chart (see below) currently has 30 price targets and 36 ratings on display. The stock rating distribution of ENFN is 50% HOLD, 25% BUY and 25% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 48.07% with an average time for these price targets to be met of 77.38 days.

Highest price target for ENFN is $11.5, Lowest price target is $11.5, average price target is $7.75.

Most recent stock forecast was given by SUMEET MODY from PIPER SANDLER on 23-Dec-2024. First documented stock forecast 15-Nov-2021.

Currently out of the existing stock ratings of ENFN, 6 are a HOLD (50%), 3 are a BUY (25%), 3 are a SELL (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$11.5

$0.4 (3.60%)

$9

3 months 11 days ago
(23-Dec-2024)

3/3 (100%)

$0.98 (9.32%)

58

Buy

$11

10 months 24 days ago
(10-May-2024)

3/7 (42.86%)

$2.65 (31.74%)

292

Sell

$9

$-2.1 (-18.92%)

$10

1 years 21 days ago
(13-Mar-2024)

2/4 (50%)

$-0.32 (-3.43%)

87

Sell

$8

$-3.1 (-27.93%)

$10

1 years 1 months 6 days ago
(28-Feb-2024)

3/4 (75%)

$-0.73 (-8.36%)

113

Sell

$9

$-2.1 (-18.92%)

$12

1 years 2 months 4 days ago
(30-Jan-2024)

1/2 (50%)

$0.97 (12.08%)

17

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ENFN (Enfusion) average time for price targets to be met?

On average it took 77.38 days on average for the stock forecasts to be realized with a an average price target met ratio 48.07

Which analyst has the current highest performing score on ENFN (Enfusion) with a proven track record?

KEVIN MCVEIGH

Which analyst has the current lower performing score on ENFN (Enfusion) with a proven track record?

ALEXEI GOGOLEV

Which analyst has the most public recommendations on ENFN (Enfusion)?

Kevin Mcveigh works at UBS and has 8 price targets and 6 ratings on ENFN

Which analyst is the currently most bullish on ENFN (Enfusion)?

Parker Lane with highest potential upside - $7.39

Which analyst is the currently most reserved on ENFN (Enfusion)?

Gabriela Borges with lowest potential downside - -$3.1

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?